Evgeny Pokushalov

Last updated
Pokushalov-1.jpg

Evgeny A. Pokushalov (Tomsk, Russia, November 7, 1974) is a Russian electrophysiologist.

Contents

Professional qualifications

MD (Б-1 077979; University of Russia, 2002), PhD, Professor of Medicine

Present appointment

Deputy Director of the clinics network "New medical technologies center"; Advisor to the Chairman of the Siberian Branch of the Russian Academy of Sciences[ citation needed ]

Undergraduate education and qualifications

From 1997 to 1999 Pokushalov studied at the Residency of Cardiology in the Tomsk Research Institute of Cardiology (Russia), where he got clinical training on cardiovascular disease. He got practical skills in electrophysiologic studies both with a catheter and intraoperatively. Then he engaged in a postgraduate course of Cardiosurgery during 3 years in the Tomsk Research Institute of Cardiology (Russia), where he got practical experience in conducting scientific clinical research. He also engaged in a postgraduate trainings in Hopital Haut-Leveque, Bordeaux-Pessac, France; St Georg Hospital, Hamburg, Germany; San Raffaele University Hospital, Milan, Italy; Harvard Medical School, USA.[ citation needed ]

Clinical and scientific activity

Since the completion of the training in 1999 Pokushalov devoted his professional time to clinical cardiac electrophysiology, including both clinical and scientific activities serving as the primary operator in the electrophysiology laboratory, collecting and analyzing clinical data, initiating inner clinical studies, follow-up clinic etc. At the moment Pokushalov has presentations and original publications. His h index is 28 (the h Index considers Scopus articles published after 1995). Pokushalov took a part as a principal investigator and co-investigator in 30 international multicenter clinical studies since 2005. Since 2016 Pokushalov became a member of the Expert Council of Russian Academy of Sciences.[ citation needed ]

Membership of professional associations and colleges

Pokushalov is a member of Russian Society of Pacing and Electrophysiology, Member of European Society of Cardiology, Member of American Heart Association, Fellow member of European Society of Cardiology, Fellow member of American College of Cardiology and Fellow member of Heart Rhythm Society. Since December 2016 - Fellow of European Heart Rhythm Association.[ citation needed ]

Related Research Articles

<span class="mw-page-title-main">Cardiology</span> Branch of medicine dealing with the heart

Cardiology is the study of the heart. Cardiology is a branch of medicine that deals with disorders of the heart and the cardiovascular system. The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, valvular heart disease, and electrophysiology. Physicians who specialize in this field of medicine are called cardiologists, a specialty of internal medicine. Pediatric cardiologists are pediatricians who specialize in cardiology. Physicians who specialize in cardiac surgery are called cardiothoracic surgeons or cardiac surgeons, a specialty of general surgery.

<span class="mw-page-title-main">Botulinum toxin</span> Neurotoxic protein produced by Clostridium botulinum

Botulinum toxin, or botulinum neurotoxin, is a highly potent neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction, thus causing flaccid paralysis. The toxin causes the disease botulism. The toxin is also used commercially for medical and cosmetic purposes. Botulinum toxin is an acetylcholine release inhibitor and a neuromuscular blocking agent.

<span class="mw-page-title-main">Cardiomyopathy</span> Disease of the heart muscle

Cardiomyopathy is a group of primary diseases of the heart muscle. Early on there may be few or no symptoms. As the disease worsens, shortness of breath, feeling tired, and swelling of the legs may occur, due to the onset of heart failure. An irregular heart beat and fainting may occur. Those affected are at an increased risk of sudden cardiac death.

Fibrillation is the rapid, irregular, and unsynchronized contraction of muscle fibers. An important occurrence is with regard to the heart.

Hypertrophic cardiomyopathy is a condition in which muscle tissues of the heart become thickened without an obvious cause. The parts of the heart most commonly affected are the interventricular septum and the ventricles. This results in the heart being less able to pump blood effectively and also may cause electrical conduction problems. Specifically, within the bundle branches that conduct impulses through the interventricular septum and into the Purkinje fibers, as these are responsible for the depolarization of contractile cells of both ventricles.

<span class="mw-page-title-main">Cardiac electrophysiology</span> Science of elucidating, diagnosing, and treating the electrical activities of the heart

Cardiac electrophysiology is a branch of cardiology and basic science focusing on the electrical activities of the heart. The term is usually used in clinical context, to describe studies of such phenomena by invasive (intracardiac) catheter recording of spontaneous activity as well as of cardiac responses to programmed electrical stimulation - clinical cardiac electrophysiology. However, cardiac electrophysiology also encompasses basic research and translational research components. Specialists studying cardiac electrophysiology, either clinically or solely through research, are known as cardiac electrophysiologists.

Premature atrial contraction (PAC), also known as atrial premature complexes (APC) or atrial premature beats (APB), are a common cardiac dysrhythmia characterized by premature heartbeats originating in the atria. While the sinoatrial node typically regulates the heartbeat during normal sinus rhythm, PACs occur when another region of the atria depolarizes before the sinoatrial node and thus triggers a premature heartbeat, in contrast to escape beats, in which the normal sinoatrial node fails, leaving a non-nodal pacemaker to initiate a late beat.

<span class="mw-page-title-main">Wandering atrial pacemaker</span> Medical condition

Wandering atrial pacemaker (WAP) is an atrial rhythm where the pacemaking activity of the heart originates from different locations within the atria. This is different from normal pacemaking activity, where the sinoatrial node is responsible for each heartbeat and keeps a steady rate and rhythm. Causes of wandering atrial pacemaker are unclear, but there may be factors leading to its development. It is often seen in the young, the old, and in athletes, and rarely causes symptoms or requires treatment. Diagnosis of wandering atrial pacemaker is made by an ECG.

The following outline is provided as an overview of and topical guide to cardiology, the branch of medicine dealing with disorders of the human heart. The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, valvular heart disease and electrophysiology. Physicians who specialize in cardiology are called cardiologists.

<span class="mw-page-title-main">Amiran Revishvili</span> Russian physician (born 1956)

Amiran Shota Revishvili, born February 11, 1956, is a cardiac electrophysiologist, and Director, A.V. Vishnevsky Institute of Surgery in Moscow. He is president of the Russian Scientific Society of Clinical Electrophysiology, Arrhythmology and Cardiac Pacing, which is the Russian organizational member of the European Heart Rhythm Society network.

<span class="mw-page-title-main">Atrial fibrillation</span> Irregular beating of the atria of the heart

Atrial fibrillation is an abnormal heart rhythm (arrhythmia) characterized by rapid and irregular beating of the atrial chambers of the heart. It often begins as short periods of abnormal beating, which become longer or continuous over time. It may also start as other forms of arrhythmia such as atrial flutter that then transform into AF.

<span class="mw-page-title-main">Myocardial bridge</span> Medical condition

A myocardial bridge (MB) is a congenital heart defect in which one of the coronary arteries tunnels through the heart muscle itself (myocardium). In normal patients, the coronary arteries rest on top of the heart muscle and feed blood down into smaller vessels which then take blood into the heart muscle itself. However, if a band of muscle forms around one of the coronary arteries during the fetal stage of development, then a myocardial bridge is formed – a "bridge" of heart muscle over the artery. Each time the heart squeezes to pump blood, the band of muscle exerts pressure and constricts the artery, reducing blood flow to the heart. This defect is present from birth. It is important to note that even a very thin ex. <1 mm and/or short ex. 20 mm MB can cause significant symptoms. MBs can range from a few mm in length to 10 cm or more. The overall prevalence of myocardial bridge is 19%, although its prevalence found by autopsy is much higher (42%).

<span class="mw-page-title-main">Arrhythmia</span> Group of medical conditions characterized by irregular heartbeat

Arrhythmias, also known as cardiac arrhythmias, heart arrhythmias, or dysrhythmias, are irregularities in the heartbeat, including when it is too fast or too slow. A resting heart rate that is too fast – above 100 beats per minute in adults – is called tachycardia, and a resting heart rate that is too slow – below 60 beats per minute – is called bradycardia. Some types of arrhythmias have no symptoms. Symptoms, when present, may include palpitations or feeling a pause between heartbeats. In more serious cases, there may be lightheadedness, passing out, shortness of breath, chest pain, or decreased level of consciousness. While most cases of arrhythmia are not serious, some predispose a person to complications such as stroke or heart failure. Others may result in sudden death.

<span class="mw-page-title-main">Ohio State Richard M. Ross Heart Hospital</span> Cardiovascular hospital in Columbus, Ohio, US

The Ohio State Richard M. Ross Heart Hospital is located at Ohio State University in Columbus, Ohio. The hospital specializes in cardiology, and is ranked number 46 in the United States for its heart program by U.S. News & World Report for 2020. Care is provided for patients with cardiovascular disease or peripheral vascular disease. The hospital was the first in the country to perform robotic surgery.

Paul Dorian is a Canadian physician. He is a professor of pharmacology and director of the Division of Cardiology at the University of Toronto. His primary research focus is the clinical pharmacology of antiarrhythmic drugs.

<span class="mw-page-title-main">Charles Antzelevitch</span> American cardiovascular research scientist

Charles Antzelevitch is an American cardiovascular research scientist in the fields of cardiac electrophysiology and cardiac arrhythmia syndromes.

<span class="mw-page-title-main">Mauricio de Maio</span> Brazilian plastic surgeon

Mauricio de Maio is a Brazilian plastic surgeon who works with injectable fillers and botulinum toxin. He is the co-author of three textbooks on plastic surgery.

William J. Binder is an American facial plastic surgeon. He is best known for his 1992 discovery of the use of Botox to alleviate chronic migraine.

Alan Brown Scott was an American ophthalmologist specializing in eye muscles and their disorders, such as strabismus. He is best known for his work in developing and manufacturing the drug that became known as Botox, research described as "groundbreaking" by the ASCRS.

<span class="mw-page-title-main">National Medical Research Center of Cardiology</span> Hospital in Moscow, Russia

National Medical Research Center for Cardiology named after academician Yevgeniy Chazov of the Ministry of Health of the Russian Federation is one of the leading and oldest specialized medical institutions in Russia, whose activities are aimed at diagnosing, treating and preventing cardiovascular diseases.

References

[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21]

  1. "FHRS Member Listing". Hrsonline.org. 2016-07-28. Retrieved 2016-08-27.
  2. "Новосибирский врач признан одним из ведущих кардиологов мира | РИА Новости". Ria.ru. 2013-09-20. Retrieved 2016-08-27.
  3. "Botulinum Toxin for Postop Afib?". Medpage Today. 2014-05-13. Retrieved 2016-08-27.
  4. "Новосибирский врач вошел в состав международного экспертного совета". Vesti.ru. 2016-06-10. Retrieved 2016-08-27.
  5. Татьяна Моноенко. "Медицина - Новосибирские кардиохирурги начали применять новый метод лечения нарушений ритма сердца - Вести Новосибирск". Nsktv.ru. Retrieved 2016-08-27.
  6. "Врач из Новосибирска стал одним из лучших кардиологов в мире - МедНовости". MedPortal.ru. 2013-09-23. Retrieved 2016-08-27.
  7. "Сетевое издание "Медицина и образование в Сибири"". Ngmu.ru. Retrieved 2016-08-27.
  8. Покушалов, Евгений Анатольевич. "Радиочастотная катетерная аблация трепетания предсердий - автореферат диссертации по медицине скачать бесплатно на тему 'Сердечно-сосудистая хирургия', специальность ВАК РФ 14.00.44". Medical-diss.com. Retrieved 2016-08-27.
  9. Michelle Fay Cortez (2015-05-14). "Botulism Shot to the Heart May Wipe Out Erratic Rhythms". Bloomberg.com. Retrieved 2016-08-27.
  10. "Study finds botulinum toxin injections in epicardial fat pads reduce AF risk immediately following surgery and after one year of follow-up". News-medical.net. 2015-05-15. Retrieved 2016-08-27.
  11. "Botulinum toxin may help even the heart". Nyheadache.com. Retrieved 2016-08-27.
  12. "Botox: An Rx for Irregular Heartbeat After Cardiac Surgery? - Drugs.com MedNews". Drugs.com. Retrieved 2016-08-27.
  13. "Botox: An Rx for Irregular Heartbeat After Cardiac Surgery?". Consumer.healthday.com. 2015-05-14. Archived from the original on 2016-08-28. Retrieved 2016-08-27.
  14. "Botox: An Rx for Irregular Heartbeat After Cardiac Surgery? – WebMD". Webmd.com. 2015-05-14. Retrieved 2016-08-27.
  15. "Health | The Latest News from the Pittsburgh Post-Gazette". Post-gazette.com. Retrieved 2016-08-27.
  16. "Botox may eliminate erratic heart rhythms after surgery". UPI.com. 2015-05-15. Retrieved 2016-08-27.
  17. "Botox: An Rx for Irregular Heartbeat After Cardiac Surgery?". FirstWord Pharma. 2015-05-15. Retrieved 2016-08-27.
  18. Johnson, Kate. "Can Botulinum Toxin Suppress Afib Long Term?". Medpage Today. Retrieved 2016-08-27.
  19. "LBCT Botox". Hrsonline.org. 2015-05-14. Archived from the original on 2016-04-14. Retrieved 2016-08-27.
  20. "Botox: An Rx for Irregular Heartbeat After Cardiac Surgery?". Archived from the original on 2015-05-20. Retrieved 2015-05-19.
  21. Boyles, Salynn. "Botulinum Toxin May Prevent Afib Following Bypass". Medpage Today. Retrieved 2016-08-27.